Tıbbi Onkoloji

Uzm. Dr. Barış Gezici

Hekim ve araştırmacı İzmir Şehir Hastanesi İzmir
Kurum sayfasını aç
Düzeltme öner

Bu sizin profiliniz mi? Sahiplenin, bilgilerinizi doğrulayın.

Profili sahiplen

Güven

Bu bilgiler nereden geliyor?

Her bilginin yanında kaynağı yazar. Yanlış bir şey görürseniz düzeltme önerebilirsiniz.

  • UzmanlıkTıbbi Onkolojisaglik.gov.trKaynaktan
  • Kurumİzmir Şehir Hastanesisaglik.gov.trKaynaktan
  • Yayınlar10 yayınOpenAlex, Europe PMCKaynaktan
  • ORCID0000-0003-1151-6523ORCIDKaynaktan
  • Son eşitleme5 Kasım 2026 09:07https://izmirsehir.saglik.gov.tr/TR-1046789/doktorlarimiz.html#baris-gezicisaglik.gov.tr

Bilimsel çalışmalar

Yayınlar

10 yayın

  1. Immune-related adverse events as predictors of pathological complete response in early-stage triple-negative breast cancer treated with pembrolizumab

    Immunotherapy, 2026

    DOI 10.1080/1750743x.2026.2662201 PMID 42011533 4 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  2. Successful rapid desensitization with 5-fluorouracil in a patient with metastatic sigmoid colon cancer: A case report

    Journal of Oncology Pharmacy Practice, 2026

    DOI 10.1177/10781552261478571 PMID 42585552 Kaynak: OpenAlex

  3. Real‐world effectiveness and safety of sacituzumab govitecan in patients with metastatic or unresectable locally advanced triple‐negative breast cancer: A multicenter study by the Turkish Oncology Group

    International Journal of Cancer, 2025

    DOI 10.1002/ijc.70213 PMID 41147655 3 atıf (Europe PMC) Kaynak: OpenAlex

  4. Prevalence of Insomnia and Associated Factors in Female Patients Undergoing Chemotherapy

    Nature and science of sleep, 2025

    DOI 10.2147/nss.s554960 PMID 41084526 1 atıf (Europe PMC) Açık erişimli tam metinKaynak: Europe PMC

  5. CT-230 Evaluation of BK Polyomavirus Infection Frequency and Risk Factors Following Allogeneic Stem Cell Transplantation (allo-SCT): A Single Center Experience

    Clinical Lymphoma Myeloma & Leukemia, 2023

    DOI 10.1016/s2152-2650(23)01500-8 Kaynak: OpenAlex

  6. POSTER: CT-232 Evaluation of the Effects of Cytomegalovirus and BK Polyomavirus Infections on Overall Survival Following Allogeneic Stem Cell Transplantation: A Single Center Experience

    Clinical Lymphoma Myeloma & Leukemia, 2023

    DOI 10.1016/s2152-2650(23)00889-3 Kaynak: OpenAlex

  7. CT-232 Evaluation of the Effects of Cytomegalovirus and BK Polyomavirus Infections on Overall Survival Following Allogeneic Stem Cell Transplantation: A Single Center Experience

    Clinical Lymphoma Myeloma & Leukemia, 2023

    DOI 10.1016/s2152-2650(23)01501-x Kaynak: OpenAlex

  8. POSTER: CT-127 Evaluation of Cytomegalovirus Infection/Disease Frequency and Risk Factors Following Allogeneic Stem Cell Transplantation: A Single Center Experience

    Clinical Lymphoma Myeloma & Leukemia, 2023

    DOI 10.1016/s2152-2650(23)00914-x Kaynak: OpenAlex

  9. CT-127 Evaluation of Cytomegalovirus Infection/Disease Frequency and Risk Factors Following Allogeneic Stem Cell Transplantation: A Single Center Experience

    Clinical Lymphoma Myeloma & Leukemia, 2023

    DOI 10.1016/s2152-2650(23)01488-x Açık erişimli tam metinKaynak: OpenAlex

  10. POSTER: CT-230 Evaluation of BK Polyomavirus Infection Frequency and Risk Factors Following Allogeneic Stem Cell Transplantation (allo-SCT): A Single Center Experience

    Clinical Lymphoma Myeloma & Leukemia, 2023

    DOI 10.1016/s2152-2650(23)00888-1 Kaynak: OpenAlex